Conceptio › Archive › HAL (France)
HAL (France)open access

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial

K.L. Jhaveri et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
ER positive, ESR1 mutation, EMBER-3, SERD, 2, 0, Updated OS, 1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 464227
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.